Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study.

Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T; German Competence Network for Heart Failure.; German Competence Network for HIV AIDS..

HIV Clin Trials. 2010 May-Jun;11(3):156-62. doi: 10.1310/hct1103-156.

PMID:
20739268
2.

Cardiac diastolic dysfunction is prevalent in HIV-infected patients.

Nayak G, Ferguson M, Tribble DR, Porter CK, Rapena R, Marchicelli M, Decker CF.

AIDS Patient Care STDS. 2009 Apr;23(4):231-8. doi: 10.1089/apc.2008.0142.

PMID:
19281430
3.

Assessment of cardiac diastolic dysfunction in HIV-infected people without cardiovascular symptoms in China.

Luo L, Ye Y, Liu Z, Zuo L, Li Y, Han Y, Qiu Z, Li L, Zeng Y, Li TS.

Int J STD AIDS. 2010 Dec;21(12):814-8. doi: 10.1258/ijsa.2010.010168.

PMID:
21297089
4.

Longitudinal assessment of cardiac diastolic function in HIV-infected patients.

Blaylock JM, Byers DK, Gibbs BT, Nayak G, Ferguson M, Tribble DR, Porter C, Decker CF.

Int J STD AIDS. 2012 Feb;23(2):105-10. doi: 10.1258/ijsa.2011.011099.

PMID:
22422684
5.

Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study.

Sveälv BG, Täng MS, Klingberg E, Forsblad-d'Elia H, Bergfeldt L.

Scand J Rheumatol. 2015;44(2):111-7. doi: 10.3109/03009742.2014.953201. Epub 2014 Nov 25.

PMID:
25421143
6.

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, d'Arminio Monforte A, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD; DAD study group..

AIDS. 2003 May 23;17(8):1179-93.

PMID:
12819520
7.

Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.

Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N.

Clin Res Cardiol. 2013 Mar;102(3):203-13. doi: 10.1007/s00392-012-0519-0. Epub 2012 Nov 2.

PMID:
23117698
8.

[Prevalence of cardiovascular risk factors in HIV-infected patients].

Jericó C, Knobel H, Sorli ML, Montero M, Guelar A, Pedro-Botet J.

Rev Clin Esp. 2006 Dec;206(11):556-9. Spanish.

PMID:
17178075
9.

Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.

Jantarapakde J, Phanuphak N, Chaturawit C, Pengnonyang S, Mathajittiphan P, Takamtha P, Dungjun N, Pinyakorn S, Pima W, Prasithsirikul W, Phanuphak P.

AIDS Patient Care STDS. 2014 Jul;28(7):331-40. doi: 10.1089/apc.2013.0294. Epub 2014 Jun 10.

PMID:
24914459
10.

Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy.

Galli L, Salpietro S, Pellicciotta G, Galliani A, Piatti P, Hasson H, Guffanti M, Gianotti N, Bigoloni A, Lazzarin A, Castagna A.

Eur J Epidemiol. 2012 Aug;27(8):657-65. doi: 10.1007/s10654-012-9707-5. Epub 2012 Jun 22.

PMID:
22722952
11.

Prospective echocardiographic assessment of cardiac structure and function in Chinese persons living with HIV.

Luo L, Zeng Y, Li T, Lv W, Wang H, Guo F, Han Y, Xie J, Qiu Z, Li Y, Song X, Zhu T, Zhang X, Li L, Ye Y, He Y, Lu H, Huang A, Tang X, Wang H, Zhang T, Gao G, Lei J, Wu X, Sun Y, Bai J, Li K; China AIDS Clinical Trial 0810 Group..

Clin Infect Dis. 2014 May;58(10):1459-66. doi: 10.1093/cid/ciu086. Epub 2014 Feb 25.

PMID:
24569532
12.

Aging and HIV infection: a comparison between older HIV-infected persons and the general population.

Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P.

HIV Clin Trials. 2010 Mar-Apr;11(2):100-9. doi: 10.1310/hct1102-100.

PMID:
20542846
13.

Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.

Baekken M, Os I, Sandvik L, Oektedalen O.

J Hypertens. 2008 Nov;26(11):2126-33. doi: 10.1097/HJH.0b013e32830ef5fb.

PMID:
18854751
14.

Hypertension in HIV-infected patients: prevalence and related factors.

Jericó C, Knobel H, Montero M, Sorli ML, Guelar A, Gimeno JL, Saballs P, López-Colomés JL, Pedro-Botet J.

Am J Hypertens. 2005 Nov;18(11):1396-401.

PMID:
16280270
15.

Distribution and determinants of Doppler-derived diastolic flow indices in African Americans: the Jackson Heart Study (JHS).

Samdarshi TE, Taylor HA, Edwards DQ, Liebson PR, Sarpong DF, Shreenivas SS, Howard G, Garrison RJ, Fox ER.

Am Heart J. 2009 Aug;158(2):209-16. doi: 10.1016/j.ahj.2009.05.020.

16.

Prevalence and factors associated with a prolonged QTc interval in a cohort of asymptomatic HIV-infected patients.

Moreno T, Pérez I, Isasti G, Cabrera F, Santos J, Palacios R.

AIDS Res Hum Retroviruses. 2013 Sep;29(9):1195-8. doi: 10.1089/AID.2013.0061. Epub 2013 May 31.

PMID:
23638650
17.
18.

Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.

Masiá M, Padilla S, Bernal E, Almenar MV, Molina J, Hernández I, Graells ML, Gutiérrez F.

Clin Ther. 2007 Jul;29(7):1448-55.

PMID:
17825696
19.

Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.

Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, Fiocchi F, Zona S, Loria P, Esposito R, Palella F.

Clin Infect Dis. 2008 Jul 15;47(2):250-7. doi: 10.1086/589294.

PMID:
18532884
20.

Incidence of diabetes mellitus in a population-based cohort of HIV-infected and non-HIV-infected persons: the impact of clinical and therapeutic factors over time.

Tripathi A, Liese AD, Jerrell JM, Zhang J, Rizvi AA, Albrecht H, Duffus WA.

Diabet Med. 2014 Oct;31(10):1185-93. doi: 10.1111/dme.12455. Epub 2014 Apr 28.

PMID:
24673640

Supplemental Content

Support Center